scispace - formally typeset
S

Sara R. Savage

Researcher at Baylor College of Medicine

Publications -  27
Citations -  1970

Sara R. Savage is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Proteogenomics & Cancer. The author has an hindex of 11, co-authored 24 publications receiving 677 citations. Previous affiliations of Sara R. Savage include Miami University & Vanderbilt University Medical Center.

Papers
More filters
Journal ArticleDOI

Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities.

Suhas Vasaikar, +82 more
- 02 May 2019 - 
TL;DR: Comparative proteomic and phosphoproteomic analysis of paired tumor and normal adjacent tissues produced a catalog of colon cancer-associated proteins and phosphosites, including known and putative new biomarkers, drug targets, and cancer/testis antigens, which suggested glycolysis as a potential target to overcome the resistance of MSI-H tumors to immune checkpoint blockade.
Journal ArticleDOI

Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

Michael A. Gillette, +189 more
- 09 Jul 2020 - 
TL;DR: Comprehensive proteogenomic characterization of 110 tumors and 101 matched normal adjacent tissues (NATs) incorporating genomics, epigenomics, deep-scale proteomics, phosphoproteomics, and acetylproteomics identified therapeutic vulnerabilities associated with driver events involving KRAS, EGFR, and ALK.
Journal ArticleDOI

Proteogenomic Characterization of Endometrial Carcinoma.

Yongchao Dou, +219 more
- 20 Feb 2020 - 
TL;DR: A comprehensive proteogenomic characterization of endometrial carcinomas revealed possible new consequences of perturbations to the p53 and Wnt/β-catenin pathways, identified a potential role for circRNAs in the epithelial-mesenchymal transition, and provided new information about proteomic markers of clinical and genomic tumor subgroups, including relationships to known druggable pathways.
Journal ArticleDOI

Proteogenomic and metabolomic characterization of human glioblastoma

Liang-Bo Wang, +242 more
- 12 Apr 2021 - 
TL;DR: This article identified key phosphorylation events (e.g., phosphorylated PTPN11 and PLCG1) as potential switches mediating oncogenic pathway activation, as well as potential targets for EGFR-, TP53-, and RB1-altered tumors.